SAN DIEGO & BERLIN & DURHAM, N.C.--(BUSINESS WIRE)--Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally ...
Gene editing technology is being widely deployed to generate precise data about disease-causing gene mutations and networks, helping to identify optimal therapeutic targets. These approaches are ...
New York, NY [March 31, 2025] — Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected to the College of Fellows of the American ...
One year ago, the PHG Foundation report, Host genomics: lessons for infectious diseases, highlighted the promise of host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback